Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen

PURPOSE: High-risk lesions (HRLs) of the breast are an indication for chemoprevention, yet uptake is low, largely due to concerns about side effects. In 2019, low-dose (5 mg) tamoxifen was demonstrated to reduce breast cancer risk with improved tolerance. We describe chemoprevention uptake in an aca...

Descripción completa

Detalles Bibliográficos
Autores principales: Bychkovsky, Brittany, Laws, Alison, Katlin, Fisher, Hans, Marybeth, Knust Graichen, Mary, Pace, Lydia E., Scheib, Rochelle, Garber, Judy E., King, Tari A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978759/
https://www.ncbi.nlm.nih.gov/pubmed/35378642
http://dx.doi.org/10.1007/s10549-022-06577-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978759/
https://www.ncbi.nlm.nih.gov/pubmed/35378642
http://dx.doi.org/10.1007/s10549-022-06577-5

Ejemplares similares